Search research articles
Contact Us
Filters
Showing results (201-210 of 333) with videos related to
Page
of 34
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 9, 2025
Gaps in the Hepatitis C Prenatal and Postpartum Care Cascade: Rationale for Treatment in Pregnancy
Andrew B Mendlowitz, Jennifer A Flemming, Tatyana Kushner, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 14, 2023
Risk of Hepatocellular Carcinoma After Spontaneous Clearance of Hepatitis C Virus and in Noncirrhosis Chronic Hepatitis C Patients With Sustained Virological Response: A Systematic Review
Christine C Hsu, Harish Gopalakrishna, Maria Mironova, et al.
Gastroenterology
|
July 30, 2019
Increased Risk for Hepatocellular Carcinoma Persists Up to 10 Years After HCV Eradication in Patients With Baseline Cirrhosis or High FIB-4 Scores
George N Ioannou, Lauren A Beste, Pamela K Green, et al.
The Journal of Infectious Diseases
|
August 13, 2010
Prevalence, correlates, and viral dynamics of hepatitis delta among injection drug users
Lauren M Kucirka, Homayoon Farzadegan, Jordan J Feld, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
October 27, 2020
Prenatal hepatitis B screening, and hepatitis B burden among children, in Ontario: a descriptive study
Mia J Biondi, Alex Marchand-Austin, Kirby Cronin, et al.
Haematologica
|
August 4, 2006
Combination erythropoietin-hydroxyurea therapy in sickle cell disease: experience from the National Institutes of Health and a literature review
Jane A Little, Vicki R McGowan, Gregory J Kato, et al.
CMAJ Open
|
December 27, 2016
Restrictions for reimbursement of direct-acting antiviral treatment for hepatitis C virus infection in Canada: a descriptive study
Alison D Marshall, Sahar Saeed, Lisa Barrett, et al.
Infectious Diseases and Therapy
|
April 8, 2026
Efficacy and Safety of Glecaprevir/Pibrentasvir in Participants with Chronic HCV Infection and Comorbidities or Multiple Concomitant Medications: An Integrated Analysis
Curtis Cooper, Shweta A Raina, Lisa Johnson, et al.
Hepatology Communications
|
March 8, 2021
Efficacy and Safety of Cenicriviroc in Patients With Primary Sclerosing Cholangitis: PERSEUS Study
Bertus Eksteen, Christopher L Bowlus, Aldo J Montano-Loza, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
July 31, 2017
Sofosbuvir/velpatasvir in patients with hepatitis C virus genotypes 1-6 and compensated cirrhosis or advanced fibrosis
Tarik Asselah, Stefan Bourgeois, Stephen Pianko, et al.
Page
of 34
Search research articles
Search
Showing results (201-210 of 333) with videos related to
Sort By:
Page
of 34
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 9, 2025
Gaps in the Hepatitis C Prenatal and Postpartum Care Cascade: Rationale for Treatment in Pregnancy
Andrew B Mendlowitz, Jennifer A Flemming, Tatyana Kushner, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 14, 2023
Risk of Hepatocellular Carcinoma After Spontaneous Clearance of Hepatitis C Virus and in Noncirrhosis Chronic Hepatitis C Patients With Sustained Virological Response: A Systematic Review
Christine C Hsu, Harish Gopalakrishna, Maria Mironova, et al.
Gastroenterology
|
July 30, 2019
Increased Risk for Hepatocellular Carcinoma Persists Up to 10 Years After HCV Eradication in Patients With Baseline Cirrhosis or High FIB-4 Scores
George N Ioannou, Lauren A Beste, Pamela K Green, et al.
The Journal of Infectious Diseases
|
August 13, 2010
Prevalence, correlates, and viral dynamics of hepatitis delta among injection drug users
Lauren M Kucirka, Homayoon Farzadegan, Jordan J Feld, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
October 27, 2020
Prenatal hepatitis B screening, and hepatitis B burden among children, in Ontario: a descriptive study
Mia J Biondi, Alex Marchand-Austin, Kirby Cronin, et al.
Haematologica
|
August 4, 2006
Combination erythropoietin-hydroxyurea therapy in sickle cell disease: experience from the National Institutes of Health and a literature review
Jane A Little, Vicki R McGowan, Gregory J Kato, et al.
CMAJ Open
|
December 27, 2016
Restrictions for reimbursement of direct-acting antiviral treatment for hepatitis C virus infection in Canada: a descriptive study
Alison D Marshall, Sahar Saeed, Lisa Barrett, et al.
Infectious Diseases and Therapy
|
April 8, 2026
Efficacy and Safety of Glecaprevir/Pibrentasvir in Participants with Chronic HCV Infection and Comorbidities or Multiple Concomitant Medications: An Integrated Analysis
Curtis Cooper, Shweta A Raina, Lisa Johnson, et al.
Hepatology Communications
|
March 8, 2021
Efficacy and Safety of Cenicriviroc in Patients With Primary Sclerosing Cholangitis: PERSEUS Study
Bertus Eksteen, Christopher L Bowlus, Aldo J Montano-Loza, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
July 31, 2017
Sofosbuvir/velpatasvir in patients with hepatitis C virus genotypes 1-6 and compensated cirrhosis or advanced fibrosis
Tarik Asselah, Stefan Bourgeois, Stephen Pianko, et al.
Page
of 34